ÂÜÀòÂÒÂ×

Carlos Camozzi is an experienced executive in the biopharmaceutical industry, currently serving as CEO and Founder of CRC - Management Consulting GmbH since October 2018. Camozzi holds multiple leadership roles, including Chief Medical Officer at BirchBioMed Inc. and ADYA, where responsibilities involve advancing clinical programs and regulatory strategies for innovative therapies. As Chairperson of the Rare and Orphan Advisory Board at Simbec-Orion, Camozzi leads discussions among experts in rare diseases. Additionally, contributions to organizations such as GettingUp.Org and the RE(ACT) Discovery Institute reflect a commitment to patient advocacy and funding for orphan drug research. With a medical background as a Clinical Pharmacologist, Paediatrician, and MD from reputable institutions, Camozzi has significant expertise in orphan drugs and rare diseases, demonstrated through roles with multiple companies and advisory positions since 2016.